Stockreport

Acrivon Therapeutics Announces $130 Million Private Placement Financing

Acrivon Therapeutics, Inc.  (ACRV) 
PDF WATERTOWN, Mass, April 09, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical [Read more]